FR2202686A1 - Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia - Google Patents

Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia

Info

Publication number
FR2202686A1
FR2202686A1 FR7236497A FR7236497A FR2202686A1 FR 2202686 A1 FR2202686 A1 FR 2202686A1 FR 7236497 A FR7236497 A FR 7236497A FR 7236497 A FR7236497 A FR 7236497A FR 2202686 A1 FR2202686 A1 FR 2202686A1
Authority
FR
France
Prior art keywords
medicaments
dyslipemia
nicotinyl
ingredient
acetate hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7236497A
Other languages
French (fr)
Other versions
FR2202686B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Priority to FR7236497A priority Critical patent/FR2202686A1/en
Publication of FR2202686A1 publication Critical patent/FR2202686A1/en
Application granted granted Critical
Publication of FR2202686B1 publication Critical patent/FR2202686B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Medicaments contain (I): hydrochloride (I) and another medicament such as vasodilators, heparinoids, psychostimulants, plaquette antiaggregants, cardiotonics, respiratory analeptics and vit. P factors. (I) is prepd. by addition of pyridine methanol to theophylline-7-acetyl chloride.
FR7236497A 1972-10-13 1972-10-13 Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia Granted FR2202686A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7236497A FR2202686A1 (en) 1972-10-13 1972-10-13 Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7236497A FR2202686A1 (en) 1972-10-13 1972-10-13 Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia

Publications (2)

Publication Number Publication Date
FR2202686A1 true FR2202686A1 (en) 1974-05-10
FR2202686B1 FR2202686B1 (en) 1975-10-31

Family

ID=9105659

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7236497A Granted FR2202686A1 (en) 1972-10-13 1972-10-13 Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia

Country Status (1)

Country Link
FR (1) FR2202686A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227356A2 (en) * 1985-12-04 1987-07-01 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. The use of depogen in the treatment of restricted blood circulation
EP0498268A2 (en) * 1991-02-06 1992-08-12 POLI INDUSTRIA CHIMICA S.p.A. 5-Oxo-L-proline derivatives and pharmaceutical use thereof
JP2019011336A (en) * 2018-09-05 2019-01-24 テックフィールズ インコーポレイテッド Nsaia prodrugs with extremely fast skin and membrane penetration speed and use thereof for novel medicines

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2101120A1 (en) * 1970-08-25 1972-03-31 Socibre

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2101120A1 (en) * 1970-08-25 1972-03-31 Socibre

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0227356A2 (en) * 1985-12-04 1987-07-01 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. The use of depogen in the treatment of restricted blood circulation
EP0227356A3 (en) * 1985-12-04 1989-12-13 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. The use of depogen in the treatment of restricted blood circulation
EP0498268A2 (en) * 1991-02-06 1992-08-12 POLI INDUSTRIA CHIMICA S.p.A. 5-Oxo-L-proline derivatives and pharmaceutical use thereof
EP0498268A3 (en) * 1991-02-06 1993-12-08 Poli Ind Chimica Spa 5-oxo-l-proline derivatives and pharmaceutical use thereof
JP2019011336A (en) * 2018-09-05 2019-01-24 テックフィールズ インコーポレイテッド Nsaia prodrugs with extremely fast skin and membrane penetration speed and use thereof for novel medicines

Also Published As

Publication number Publication date
FR2202686B1 (en) 1975-10-31

Similar Documents

Publication Publication Date Title
ES421538A1 (en) 1-Aryloxy-3-ureidoalkylamino-2-propanols
SE427795B (en) Orthodontic rectifier of the type that is unformed in the horizontal plane
ES462175A1 (en) Pharmaceutical compositions
HU175142B (en) Process for producing insulin composition of prolonged activity, with weak antigenic effectivity
NL7606908A (en) BENZOFURAN CARBONIC ACID DERIVATIVES AND PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING THEM.
NO146396C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIMIDINE DERIVATIVES.
AU466549B2 (en) Apparatus for controlled selective separation of undesirable constituents from blood to achieve a thera hsu tic effect
ES369624A1 (en) Alkanolamine derivatives
FR2202686A1 (en) Nicotinyl theophylline acetate hydrochloride - ingredient in medicaments for circulatory disorders and dyslipemia
ES432848A2 (en) Alkanolamine derivatives
IL40111A0 (en) 2-aminobenzimidazole-1-carboxylic acid derivatives,their preparation and their use as fungicides and bactericides
EG11798A (en) Process for the preparation of(1-imidazolyl-(1-(4,(4"chlorophenyl)-phenoxy)-3,3-dimethylbutan-2-one and its salts,and their use as medicaments
AU454611B2 (en) Thienyl-fattyacid derivatives processes for their production, and their use as therapeutic agents
SE7504972L (en) SCISSORS INTENDED FOR PICKING UP OF HIGH SPEED RUNNING ROLLS, IN PARTICULAR
NZ181785A (en) Stimulating lactation in mammals by administration of 1-(1-4,4-bis-(4-fluorophenyl)-butyl)-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one
FR2376148A1 (en) NEW DISUBSTITLED PIPERAZINES, THEIR METHODS OF PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
CA938294A (en) Manufacture of 1,1'-disubstituted-4,4'-bipyridylium salts
AU2169677A (en) Medicament to be taken orally for regulating the circulation of blood
FI51478C (en) Process for the preparation of therapeutically active acid addition salts of 1,3,4,9b-tetrahydro-2 (2H) -indeno (1,2-c) pyridine derivatives.
IL45337A0 (en) Therapeutical composition containing an isonicotinic acid derivative for the treatment of mycobacterioses
GB1173615A (en) Calcium Succinate
OTSUKA et al. Relation between rate of P32 deposition and effect of deep therapy in oesophageal cancer
CA529114A (en) Therapeutic agent for the treatment of tuberculous diseases, especially tuberculosis of the lungs
FR2092780A2 (en) 2-oxa-3-oxo-17-beta undecanoyloxy estra-4,9,11-triene - - long acting anabolic agent
JPS5247913A (en) Method of preparing concentrated and stable inosine solution

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse